Wells Fargo analyst Joseph McKay downgrades Centennial Resource Dev (NASDAQ:CDEV) from Equal-Weight to Underweight and lowers the price target from $12 to $11.
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study.
